Inhibition of infection-mediated preterm birth by administration of broad spectrum chemokine inhibitor in mice

Journal of Cellular and Molecular Medicine

Volumn 18, Issue 9, 2014, Pages 1816-1829

  Shynlova, Oksana ^a,b   Dorogin, Anna ^a   Li, Yunqing ^a,b   Lye, Stephen ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Chemokine inhibitor; Infection; Leucocyte infiltration; Preterm labour; Uterus

Indexed keywords

MUS;

ANTIINFLAMMATORY AGENT; CHEMOKINE; LIPOPOLYSACCHARIDE;

ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; MYOMETRIUM; NEUTROPHIL CHEMOTAXIS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREMATURE BIRTH; UTERUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CHEMOKINES; FEMALE; HUMANS; LIPOPOLYSACCHARIDES; MICE, INBRED ICR; MYOMETRIUM; NEUTROPHIL INFILTRATION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREMATURE BIRTH; UTERUS;

EID: 84908235161     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12307     Document Type: Article

References (46)

1. Lawn JE, Cousens S, Zupan J. 4 million neonatal deaths: when? Where? Why? Lancet. 2005; 365: 891-900.
2. Howson CP. Born too soon: global action report on preterm birth. Geneva: WHO, 2012.
3. Too early, too small: a profile of small babies across Canada. Ottawa: Canadian Institute for Health Information, 2009.
4. Shynlova O, Nedd-Roderique T, Li Y, et al. Infiltration of myeloid cells into decidua is a critical early event in the labour cascade and post-partum uterine remodelling. J Cell Mol Med. 2013; 17: 311-24.
5. Shynlova O, Nedd-Roderique T, Li Y, et al. Myometrial immune cells contribute to term parturition, preterm labour and post-partum involution in mice. J Cell Mol Med. 2013; 17: 90-102.
6. Orsi NM, Tribe RM. Cytokine networks and the regulation of uterine function in pregnancy and parturition. J Neuroendocrinol. 2008; 20: 462-9.
7. Hamilton S, Oomomian Y, Stephen G, et al. Macrophages infiltrate the human and rat decidua during term and preterm labor: evidence that decidual inflammation precedes labor. Biol Reprod. 2012; 86: 39.
8. Thomson AJ, Telfer JF, Young A, et al. Leukocytes infiltrate the myometrium during human parturition: further evidence that labour is an inflammatory process. Hum Reprod. 1999; 14: 229-36.
9. Keski-Nisula LT, Aalto ML, Kirkinen PP, et al. Myometrial inflammation in human delivery and its association with labor and infection. Am J Clin Pathol. 2003; 120: 217-24.
10. Kayisli UA, Mahutte NG, Arici A. Uterine chemokines in reproductive physiology and pathology. Am J Reprod Immunol. 2002; 47: 213-21.
11. Goldenberg RL, Andrews WW, Hauth JC. Choriodecidual infection and preterm birth. Nutr Rev. 2002; 60: S19-25.
12. Hagberg H, Wennerholm UB, Savman K. Sequelae of chorioamnionitis. Curr Opin Infect Dis. 2002; 15: 301-6.
13. Romero R, Espinoza J, Goncalves LF, et al. Inflammation in preterm and term labour and delivery. Semin Fetal Neonatal Med. 2006; 11: 317-26.
14. Lee HJ, Lee K, Lee DG, et al. Chemokine (C-X-C Motif) ligand 12 is associated with gallbladder carcinoma progression and is a novel independent poor prognostic factor. Clin Cancer Res. 2012; 18: 3270-80.
15. Yan L, Anderson GM, DeWitte M, et al. Therapeutic potential of cytokine and chemokine antagonists in cancer therapy. Eur J Cancer. 2006; 42: 793-802.
16. Choi WT, An J. Biology and clinical relevance of chemokines and chemokine receptors CXCR4 and CCR5 in human diseases. Exp Biol Med. 2011; 236: 637-47.
17. Burger JA, Stewart DJ. CXCR4 chemokine receptor antagonists: perspectives in SCLC. Expert Opin Investig Drugs. 2009; 18: 481-90.
18. Burger JA. Chemokines and chemokine receptors in chronic lymphocytic leukemia (CLL): from understanding the basics towards therapeutic targeting. Semin Cancer Biol. 2010; 20: 424-30.
19. Lieberman-Blum SS, Fung HB, Bandres JC. Maraviroc: a CCR5-receptor antagonist for the treatment of HIV-1 infection. Clin Ther. 2008; 30: 1228-50.
20. Anders HJ, Vielhauer V, Frink M, et al. A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation. J Clin Invest. 2002; 109: 251-9.
21. Bedke J, Kiss E, Schaefer L, et al. Beneficial effects of CCR1 blockade on the progression of chronic renal allograft damage. Am J Transplant. 2007; 7: 527-37.
22. Ninichuk V, Anders HJ. Chemokine receptor CCR1: a new target for progressive kidney disease. Am J Nephrol. 2005; 25: 365-72.
23. Urushihara M, Ohashi N, Miyata K, et al. Addition of angiotensin II type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis. Hypertension. 2011; 57: 586-93.
24. Eksteen B, Adams DH. GSK-1605786, a selective small-molecule antagonist of the CCR9 chemokine receptor for the treatment of Crohn's disease. IDrugs. 2010; 13: 472-81.
25. Walters MJ, Wang Y, Lai N, et al. Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for treatment of inflammatory bowel disease. J Pharmacol Exp Ther. 2010; 335: 61-9.
26. Tsai LK, Wang Z, Munasinghe J, et al. Mesenchymal stem cells primed with valproate and lithium robustly migrate to infarcted regions and facilitate recovery in a stroke model. Stroke. 2011; 42: 2932-9.
27. Kim JM, Lee YH, Ku CR, et al. The cyclic pentapeptide d-Arg3FC131, a CXCR4 antagonist, induces apoptosis of somatotrope tumor and inhibits tumor growth in nude mice. Endocrinology. 2011; 152: 536-44.
28. Grainger DJ, Reckless J. Broad-spectrum chemokine inhibitors (BSCIs) and their anti-inflammatory effects in vivo. Biochem Pharmacol. 2003; 65: 1027-34.
29. Reckless J, Tatalick L, Wilbert S, et al. Broad-spectrum chemokine inhibition reduces vascular macrophage accumulation and collagenolysis consistent with plaque stabilization in mice. J Vasc Res. 2005; 42: 492-502.
30. Naidu BV, Farivar AS, Krishnadasan B, et al. Broad-spectrum chemokine inhibition ameliorates experimental obliterative bronchiolitis. Ann Thorac Surg. 2003; 75: 1118-22.
31. Grainger DJ, Lever AM. Blockade of chemokine-induced signalling inhibits CCR5-dependent HIV infection in vitro without blocking gp120/CCR5 interaction. Retrovirology. 2005; 2: 23.
32. Hirsch E, Filipovich Y, Mahendroo M. Signaling via the type I IL-1 and TNF receptors is necessary for bacterially induced preterm labor in a murine model. Am J Obstet Gynecol. 2006; 194: 1334-40.
33. Taylor PR, Brown GD, Geldhof AB, et al. Pattern recognition receptors and differentiation antigens define murine myeloid cell heterogeneity ex vivo. Eur J Immunol. 2003; 33: 2090-7.
34. Keelan JA, Blumenstein M, Helliwell RJ, et al. Cytokines, prostaglandins and parturition-a review. Placenta. 2003; 24: S33-46.
35. Naidu BV, Farivar AS, Woolley SM, et al. Novel broad-spectrum chemokine inhibitor protects against lung ischemia-reperfusion injury. J Heart Lung Transplant. 2004; 23: 128-34.
36. Beech JS, Reckless J, Mosedale DE, et al. Neuroprotection in ischemia-reperfusion injury: an antiinflammatory approach using a novel broad-spectrum chemokine inhibitor. J Cereb Blood Flow Metab. 2001; 21: 683-9.
37. Berkkanoglu M, Zhang L, Ulukus M, et al. Inhibition of chemokines prevents intraperitoneal adhesions in mice. Hum Reprod. 2005; 20: 3047-52.
38. Kayisli UA, Berkkanoglu M, Zhang L, et al. The broad-spectrum chemokine inhibitor NR58-3.14.3 suppresses the implantation and survival of human endometrial implants in the nude mice endometriosis model. Reprod Sci. 2007; 14: 825-35.
39. Miklos S, Mueller G, Chang Y, et al. Preventive usage of broad spectrum chemokine inhibitor NR58-3.14.3 reduces the severity of pulmonary and hepatic graft-versus-host disease. Int J Hematol. 2009; 89: 383-97.
40. Fox DJ, Reckless J, Wilbert SM, et al. Identification of 3-(acylamino)azepan-2-ones as stable broad-spectrum chemokine inhibitors resistant to metabolism in vivo. J Med Chem. 2005; 48: 867-74.
41. Fox DJ, Reckless J, Lingard H, et al. Highly potent, orally available anti-inflammatory broad-spectrum chemokine inhibitors. J Med Chem. 2009; 52: 3591-5.
42. Reckless J, Tatalick LM, Grainger DJ. The pan-chemokine inhibitor NR58-3.14.3 abolishes tumour necrosis factor-alpha accumulation and leucocyte recruitment induced by lipopolysaccharide in vivo. Immunology. 2001; 103: 244-54.
43. Ferone D, van Hagen PM, Pivonello R, et al. Physiological and pathophysiological role of somatostatin receptors in the human thymus. Eur J Endocrinol. 2000; 143: S27-34.
44. Landa JI, Alvarez SJ, Grau M, et al. Somatostatin reduces the levels of tumor necrosis factor alpha in a rat model of endotoxemia induced by lipopolysaccharide. Res Exp Med. 1995; 195: 317-25.
45. Gonzalez-Rey E, Chorny A, Robledo G, et al. Cortistatin, a new antiinflammatory peptide with therapeutic effect on lethal endotoxemia. J Exp Med. 2006; 203: 563-71.
46. Sener G, Cetinel S, Erkanli G, et al. Octreotide ameliorates sepsis-induced pelvic inflammation in female rats by a neutrophil-dependent mechanism. Peptides. 2005; 26: 493-9.